Contact
searchSearch
HMP Global

Stroke & Neurovascular Interventions Topic Center

Features

Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Interview
Carotid Webs in Young Women: Diagnosis and Treatment
02/12/2025
Bruce Perler, MD
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD,...
02/12/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Stroke Solutions
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
02/05/2025
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features...
02/05/2025
Vascular Disease Management
Dr Korngold
ISET 2025
An Industry Perspective on the Carotid Space
02/03/2025
Ethan C. Korngold, MD
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief...
02/03/2025
Vascular Disease Management
Stroke Advocacy
Philips and Medtronic Advocacy Partnership Aims to Help Accelerate Access to Life-saving Treatments
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the...
10/24/2024
Vascular Disease Management
Case Report
Carotid Web as Etiology of Recurrent Embolic Ischemic Stroke
07/15/2024
Rachel Shatanof, MD; Simon Gaviria-Valencia, MD; Francisco Ujueta, MD, MS; Arman Gill, MD; David Paniagua, MD
Carotid webs are nonatherosclerotic fibrous bands commonly found on the carotid bulb's posterior margin. Little is known about their pathogenesis. It is hypothesized that carotid webs are congenital abnormalities that proliferate in response...
Carotid webs are nonatherosclerotic fibrous bands commonly found on the carotid bulb's posterior margin. Little is known about their pathogenesis. It is hypothesized that carotid webs are congenital abnormalities that proliferate in response...
Carotid webs are...
07/15/2024
Vascular Disease Management
Dr Patrone
LINC 2024
How Robots Will Re-define the Standards of Endovascular Interventions
05/28/2024

Lorenzo Patrone, MD
West London Vascular and Interventional Centre, London, UK

Lorenzo Patrone, MD West London Vascu...
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a...
05/28/2024
Vascular Disease Management
News
Finding a Faster Path to Treatment for Stroke
12/13/2023
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major...
12/13/2023
Vascular Disease Management
Case Report
Mechanical Thrombectomy for Acute Ischemic Stroke Associated With an Ipsilateral Internal Carotid Artery Web
09/21/2023
Santhosh Reddy Kantala, MD, FNVIR; Muppidi Shruthi, MD; Ranjith Kumar, MD; K. Ravinder Reddy, MD
This case report highlights the clinical trajectory of a previously healthy young man who presented with acute right hemiplegia due to left middle cerebral artery occlusion. The patient underwent successful mechanical thrombectomy.
This case report highlights the clinical trajectory of a previously healthy young man who presented with acute right hemiplegia due to left middle cerebral artery occlusion. The patient underwent successful mechanical thrombectomy.
This case report highlights the...
09/21/2023
Vascular Disease Management

Videos

Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Urgent Carotid Endarterectomy in a COVID-19 Patient: Standard Approach With Some Adjustments (Video 1)
Videos
Urgent Carotid Endarterectomy in a COVID-19 Patient: Standard Approach With Some Adjustments (Video 1)
05/07/2020
05/07/2020
Vascular Disease Management
Kölbel: Stroke in TEVAR
Videos
Kölbel: Stroke in TEVAR
02/28/2020
Tilo Kölbel, MD
Tilo Kölbel, MD
Tilo Kölbel, MD
02/28/2020
Vascular Disease Management
Dr Setayesh Sotoudehnia
Interview
Making the Impossible Possible: MR-Guided Interventional Oncology
03/27/2025
Setayesh Sotoudehnia, MD
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh...
03/27/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Dr Dania Daye
ISET 2025
AI Governance in Procedural Practices: Who and How to Decide What Algorithms to Implement
03/24/2025
Dania Daye, MD, PhD
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses...
03/24/2025
Vascular Disease Management
Dr William Gray
ISET 2025
The Next Generation of Radiation Protection Solutions: The Dynamic SMART Shield
03/21/2025
William A. Gray, MD, FACC, FSCAI; Ripal T. Gandhi, MD, FSIR, FSVM
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD,...
03/21/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Sanjay Misra
ISET 2025
Present and Future Applications of AI in Vascular Therapy
03/20/2025
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional...
03/20/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Stroke Solutions
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
02/05/2025
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features...
02/05/2025
Vascular Disease Management
Stroke Advocacy
Philips and Medtronic Advocacy Partnership Aims to Help Accelerate Access to Life-saving Treatments
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the...
10/24/2024
Vascular Disease Management
News
Finding a Faster Path to Treatment for Stroke
12/13/2023
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major...
12/13/2023
Vascular Disease Management
News
First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment
07/18/2023

Philips Press Release

Philips Press Release
Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial.
Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial.
Bicêtre Hospital in Paris,...
07/18/2023
Vascular Disease Management
News
Philips Latest Stroke Care Advancements at Annual World Stroke Congress
10/25/2022
Philips aims to help the international community advance stroke care with partners to connect information, technologies and people across the stroke care pathway, enabling care teams to work quickly and act decisively for stroke treatment.
Philips aims to help the international community advance stroke care with partners to connect information, technologies and people across the stroke care pathway, enabling care teams to work quickly and act decisively for stroke treatment.
Philips aims to help the...
10/25/2022
Vascular Disease Management
News
CIS Earns Gold Awards For Cholesterol & Blood Pressure Control
10/03/2022
OCTOBER 3, 2022 – HOUMA, LA – Cardiovascular Institute of the South (CIS) has received two gold awards from the American Heart Association for its commitment to reducing the risk of heart disease and stroke through cholesterol and blood...
OCTOBER 3, 2022 – HOUMA, LA – Cardiovascular Institute of the South (CIS) has received two gold awards from the American Heart Association for its commitment to reducing the risk of heart disease and stroke through cholesterol and blood...
OCTOBER 3, 2022 – HOUMA, LA –...
10/03/2022
Vascular Disease Management
News
BCV Announces First-In-Human Cases With GECKO System Aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures
09/07/2022
[REIMS, FRANCE – September 7, 2022] BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD,...
[REIMS, FRANCE – September 7, 2022] BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD,...
[REIMS, FRANCE – September 7,...
09/07/2022
Vascular Disease Management
News
Riverside Community Hospital Is Nationally Recognized for its Commitment to Providing High-Quality Stroke Care
06/27/2022
The American Heart Association presents Get With The Guidelines, Stroke Gold Plus award for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.
The American Heart Association presents Get With The Guidelines, Stroke Gold Plus award for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.
The American Heart Association...
06/27/2022
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use